BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200628
DTEND;VALUE=DATE:20200703
DTSTAMP:20200430T163909Z
CREATED:20191220T164248Z
LAST-MODIFIED:20200430T163909Z
UID:35676-1593302400-1593734399@globalbiodefense.com
SUMMARY:[CANCELLED] CSTE Annual Conference 2020
DESCRIPTION:For attendees that have already registered for the 2020 Annual Conference and booked hotel accommodations through CSTE’s official housing provider\, Orchid Events\, no action is required on your part. Your meeting registration will automatically be cancelled\, and a full refund will be issued via your original payment method within 30 days.  \nThe Council of State and Territorial Epidemiologists will host the CSTE Annual Conference from June 28 – July 2\, 2020 in Seattle\, Washington. \nThis event is attended by more than 1\,700 public health epidemiologists from across the country and will include workshops\, plenary sessions with leaders in the field of public health\, oral breakout sessions\, roundtable discussions\, and poster presentations. \nConference attendees meet and share their expertise in surveillance and epidemiology as well as best practices in a broad range of areas including informatics\, infectious diseases\, substance use\, immunizations\, environmental health\, occupational health\, chronic disease\, injury control\, and maternal and child health. \nPlease visit the CSTE 2020 website for more information and to register.
URL:https://globalbiodefense.com/event/cste-annual-conference-2020/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200629T133000
DTEND;TZID=America/New_York:20200629T143000
DTSTAMP:20200624T201831Z
CREATED:20200624T201628Z
LAST-MODIFIED:20200624T201831Z
UID:46424-1593437400-1593441000@globalbiodefense.com
SUMMARY:COVID-19\, Systemic Racism\, and the Responses of HBCUs: A Virtual Town Hall Discussion
DESCRIPTION:The National Academies of Sciences\, Engineering and Medicine Board on Higher Education and Workforce will host a virtual town hall on Jun 29\, 2020 to discuss COVID-19\, Systemic Racism\, and the Responses of HBCUs. \nHistorically Black Colleges and Universities (HBCUs) are among the nation’s most vital and vibrant institutions\, serving the educational needs of hundreds of thousands of students\, advancing the full spectrum of human knowledge\, and invigorating the cultural\, social\, and economic horizons of the regions they serve. And today\, these universities are at the forefront of the fight against COVID-19\, researching treatments\, keeping their states and communities informed\, and treating patients at academic medical centers.  They are also at the forefront of the nation’s struggles against institutionalized discrimination\, systemic inequality\, and anti-Black racism that are being brought to bear every day in the forms of demonstrations and advocacy in most U.S. communities. \nHow have HBCUs responded to the COVID-19 pandemic and to the recent events surrounding the murder of George Floyd?  As HBCU presidents look toward resuming in-person classes in the fall\, what have they learned from the COVID-19 crisis\, how will their institutions evolve as a result\, and what might that mean for the future of HBCUs in America?  How will HBCUs adapt to the serious financial challenges likely to arise in states and the nation in the months ahead as a consequence of COVID-19? What are HBCU campus leaders doing in preparation for a stronger and higher-profile role in terms of advocacy and leadership in directly addressing anti-Black racism in this country? \nPlease join the presidents of three of the nation’s premier HBCUs as they discuss COVID-19 and issues of racial injustice. This event is hosted by the National Academies’ Board on Higher Education and Workforce and Issues in Science and Technology and sponsored by the Kresge Foundation and the U.S. Department of Defense HBCU/MI Program. \nSpeakers include: \n\nMakola M. Abdullah\, President of Virginia State University\nMary Schmidt Campbell\, President of Spelman College\nC. Reynold Verret\, President of Xavier University of Louisiana\n\nModerated by Gilda Barabino\, President-elect of Olin College of Engineering \nPlease contact John Veras (jveras@nas.edu) for questions.
URL:https://globalbiodefense.com/event/covid-19-systemic-racism-and-the-responses-of-hbcus-a-virtual-town-hall-discussion/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/covid-19-systemic-racism-hbcu-black-colleges-nasem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200702
DTEND;VALUE=DATE:20200703
DTSTAMP:20200211T231336Z
CREATED:20200211T230408Z
LAST-MODIFIED:20200211T231336Z
UID:39295-1593648000-1593734399@globalbiodefense.com
SUMMARY:Deadline for NIBIB Technology Accelerator Challenge: Handheld Diagnostics
DESCRIPTION:NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health \nThis challenge seeks designs for non-invasive technology platforms to diagnose sickle cell disease\, malaria\, and anemia. While not constrained to any specific technology\, the inspiration for this challenge comes from the widespread availability of mobile phones and the potential for mobile phone-linked sensor technologies to non-invasively detect changes in the blood and vasculature associated with these treatable diseases. \nKey Dates\nRelease Date: January 31\, 2020\nEstimated Competition Opening Date: March 2\, 2020\nEstimated Competition Closing Date: July 2\, 2020 \nRead more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-nibib-technology-accelerator-challenge-handheld-diagnostics/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200702T110000
DTEND;TZID=America/New_York:20200702T123000
DTSTAMP:20200624T194613Z
CREATED:20200624T194613Z
LAST-MODIFIED:20200624T194613Z
UID:46421-1593687600-1593693000@globalbiodefense.com
SUMMARY:The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19
DESCRIPTION:The National Academies Board on Chemical Sciences and Technology will convene a webcast meeting on July 2\, 2020 to discuss The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19. \nThroughout the COVID-19 pandemic\, the chemical industry in the United States has maintained operating status and continues to be at the forefront of worker safety. Despite these achievements\, the pandemic exposed some of the vulnerabilities in the chemical industry’s supply chain. \nWith an increased demand for chemical products\, such as isopropyl alcohol for the production of hand sanitizer\, the United States has seen firsthand the inflexibility of the supply chain to increase or alter production. The “just-in-time” manufacturing approach that many companies previously adopted to maximize efficiency and lower costs has now presented the industry with production challenges and raises the question of how demand can be met if a disruption to the supply chain occurs. Also of note are the specialty chemical and pharmaceutical industries\, which are increasingly vulnerable as they have outsourced many of their operations overseas. \nIn the event of a global disruption or a localized disruption unique to the point of origin\, the United States risks not being able to obtain the products it critically needs—such as personal protective equipment\, medications\, and medical equipment—as has occurred in the case of COVID-19. \n This webinar\, hosted by the Chemical Sciences Roundtable\, will aim to highlight these two vulnerabilities in the supply chain: the inelasticity of the chemical supply chain and the risks posed by the overseas manufacturing of specialty and pharmaceutical chemicals. \nSpeakers include: \n\nDr. David Bem\, VP of Science and Technology and CTO at PPG Industries\, Inc.\nDr. T. Kevin Swift\, Chief Economist at American Chemistry Council\nDr. Ron Piervincenzi\, CEO of United States Pharmacopeia\n\nA recording of the webinar will be made available after the event. Click here to register for this event.
URL:https://globalbiodefense.com/event/the-u-s-chemical-supply-chain-vulnerabilities-highlighted-by-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/chemical-sciences-roundtable-nasem-covid-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200721T100000
DTEND;TZID=America/New_York:20200721T150000
DTSTAMP:20200709T183244Z
CREATED:20200709T183155Z
LAST-MODIFIED:20200709T183244Z
UID:46618-1595325600-1595343600@globalbiodefense.com
SUMMARY:COVID Complexities: Converging Threats\, Fractured Resources
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on July 21\, 2020 to discuss “COVID Complexities: Converging Threats\, Fractured Resources”. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic has taken the lives of more than 100\,000 Americans and damaged the Nation’s economy. As the country reopens\, the disease threatens the public\, now and into the foreseeable future. Federal support for state\, local\, tribal and territorial preparedness and biosurveillance will be crucial to addressing further spread of COVID-19. The Commission intends to address national policy and resource needs for response to and recovery from this crisis. \nSpeakers include: \nJared Moskowitz – Director\, Florida Division of Emergency Management \nAlexis Madrigal – Co-Founder\, The COVID Tracking Project\, and Staff Writer\, The Atlantic \nDavid Mitchell – President\, International Association of Emergency Medical Services Chiefs \nSpeakers will discuss the potential for compoundment of the biological threat\, disease-tracking needs\, hospital preparedness\, and emergency management challenges. \nPlease visit the Bipartisan Commission on Biodefense website to register for this free event.
URL:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200722T140000
DTEND;TZID=America/New_York:20200722T163000
DTSTAMP:20200709T212451Z
CREATED:20200709T212352Z
LAST-MODIFIED:20200709T212451Z
UID:46694-1595426400-1595435400@globalbiodefense.com
SUMMARY:Next Steps for Functional Genomics: A Workshop and Proceedings Release
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine (NASEM) will convene in a virtual meeting open to the public on July 22\, 2020 to unveil and summarize written proceedings a previous workshop on the future of functional genomics research. \nDuring this proceedings release\, you will have the opportunity to hear from Gene Robinson and Lauren O’Connell\, who were members of the workshop planning committee\, about important insights that were gained over the course of the workshop. \nThe workshop itself was held in February in Washington\, DC\, and included speakers\, panels\, and interactive sessions\, that explored the scientific advancements needed to utilize functional genomics to solve societal problems in areas such as conservation\, evolutionary studies\, agriculture\, energy\, defense\, human health\, and other sectors. \nOver the course of the workshop speakers and participants looked to address the current state of the science\, what lessons have been learned thus far\, what current impediments there are to further progress\, and areas where additional investments could help move the field forward. Importantly\, the workshop served as a platform for discussion within the functional genomics community. \nPlease visit the NASEM website to register. \n 
URL:https://globalbiodefense.com/event/next-steps-for-functional-genomics-a-workshop-and-proceedings-release/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://nasem.zoom.us/webinar/register/WN_HRB5dQrxRaq16gYVKyZnmA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200727
DTEND;VALUE=DATE:20200731
DTSTAMP:20191225T203815Z
CREATED:20191225T203815Z
LAST-MODIFIED:20191225T203815Z
UID:35853-1595808000-1596153599@globalbiodefense.com
SUMMARY:Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens
DESCRIPTION:The FDA and the University of Texas Medical Branch\, Galveston National Laboratory (UTMB) are sponsoring an annual training course 27-30 July 2020 on how to meet good laboratory practice (GLP) requirements in biosafety level (BSL)-4 facilities. \nThe event will be hosted at the National Ebola Training and Education Center in Omaha\, Nebraska. \nThis  course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring nonclinical data quality and integrity in BSL-4 facilities. \nPurpose of course\nThe purpose of this unique educational course is to provide a learning environment that: \n\nPromotes collaboration\nProvides tools for conducting clinical studies\nEnhances mutual understanding of clinical\, scientific\, and regulatory complexities\, and\nPromotes the data quality and integrity derived from these regulated studies.\n\nA heightened awareness of the complexities and uniqueness of high- and maximum-containment environments for high-consequence pathogens is the first step in initiating a dialog to find solutions for the planning and execution of studies where data generated will be used to support a regulatory decision. The result is a better-prepared cohesive community of clinical\, scientific\, and regulatory experts mutually engaged in\, and committed to\, the development\, research\, and approval of medical countermeasures for high-consequence pathogens. \nProfessionals who have experience with high-consequence pathogen clinical trials are encouraged to register\, including: \n\nPhysicians\nScientists\nPrincipal investigators\nPhysician assistants\nNurses and nurse practitioners\nPharmacists\nClinical laboratorians\nClinical research staff and clinical monitors\nRegulators and regulatory reviewers\nPolicy-makers\nIRB professionals\nIndustry sponsors\n\nCourse objectives and curriculum\nObjectives\n\nFormulate solutions to regulatory\, operational\, and cultural challenges for the conduct of clinical trials of medical countermeasures for high-consequence pathogens\nIdentify and mitigate risks to data quality and integrity\nResolve complexities of performing clinical trials in biocontainment / barrier nursing environment under good clinical practices (GCPs)\nGain experience conducting clinical research tasks in a mock biocontainment environment while wearing high-level personal protective equipment (PPE)\n\nCourse curriculum\n\nAddressing cultural and language barriers\nEthical considerations for placebo-controlled studies\nRegulatory expectations\nStudy monitoring\nBarrier nursing challenges\nSample integrity\nProtocol development\nOperationalizing a protocol\nProtocol driven data collection vs. clinical data\nGood documentation practices\nReporting adverse events\nInternational issues\nStakeholder roles and responsibilities\n\nBenefits of attending\n\nAttend this free course and earn continuing education (CE) credits.\nLearn from world-renowned faculty members and subject matter experts.\nApply best practices for clinical trials during an outbreak involving high-consequence pathogens.\nRecognize and prevent potential risks to data quality and integrity.\nEnhance cultural awareness and diversity involving clinical trials in geographic locations where outbreaks caused by high-consequence pathogens are frequent.\n\nAttendees will also learn from integrated scenarios\, case studies based on real-life experiences\, and expert panels\, along with lectures from experts from FDA\, the National Institutes of Health\, the NETEC\, and clinical biocontainment units (BCUs). \nPlease visit the FDA website Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens for more information and UTMB’s Registration Page. \n 
URL:https://globalbiodefense.com/event/achieving-data-quality-and-integrity-in-clinical-trials-involving-high-consequence-pathogens/
LOCATION:National Ebola Training and Education Center (NETEC)\, Omaha\, NE\, United States
CATEGORIES:Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T090000
DTEND;TZID=America/New_York:20200923T160000
DTSTAMP:20200922T212137Z
CREATED:20200822T211622Z
LAST-MODIFIED:20200922T212137Z
UID:47153-1600851600-1600876800@globalbiodefense.com
SUMMARY:Leveraging Data Science Approaches to Address Environmental Health Challenges in Africa
DESCRIPTION:Environmental Health challenges in Africa are complex\, involving a broad range of exposures\, including ambient and indoor air pollution\, electronic waste\, heavy metals\, pesticides\, vector-borne pathogens\, and climate change\, and a large proportion of the disease burden in Africa is linked to environmental factors. This session will explore unique aspects and analytic challenges of the various types of environmental health data and will highlight recent data science approaches to characterizing hazardous exposures on the African continent\, connecting environmental exposures to health outcomes\, and reducing the risk of disease connected to the environment. \nModerator:\nGwen Collman\, Acting Deputy Director\, Associate Director for Extramural Research\, National Institute of Environmental Health Sciences \nPanelists:\nKiros Berhane\, Professor and Chair\, Department of Biostatistics\, Mailman School of Public Health\, Columbia University \nCaradee Wright\, Senior Specialist Scientist\, Environment and Health Research Unit\, South African Medical Research Council \nEngineer Bainomugisha\, Associate Professor and Chair\, Department of Computer Science\, School of Computing & IT\, Makerere University \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/leveraging-data-science-approaches-to-address-environmental-health-challenges-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T130000
DTEND;TZID=America/New_York:20200923T140000
DTSTAMP:20200920T191330Z
CREATED:20200920T191330Z
LAST-MODIFIED:20200920T191330Z
UID:47120-1600866000-1600869600@globalbiodefense.com
SUMMARY:The Effects of COVID-19 on Latin America and the Economic Outlook
DESCRIPTION:Please join the CSIS Americas Program and the CSIS Economics Program for a discussion on how the Covid-19 pandemic is affecting the outlook in Latin America. The ongoing surge in Covid-19 cases across the region raises questions about the timing of recovery\, adequacy of macroeconomic responses\, and the role of private and official sectors in responding to the unprecedented health and economic crises. This event will explore these issues\, as well as sector-specific outlooks in the wake of the pandemic\, and the outlook for sovereign and corporate debt. \nFeaturing a discussion with Geoffrey Okamoto\, Deputy First Managing Director\, International Monetary Fund. \nFollowed by a panel discussion: \n\nChris Campbell\, Chief Strategist\, Duff & Phelps Institute\nKevin Gallagher\, Professor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\nSamar Maziad\, Vice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\nModerated by Stephanie Segal\, Senior Fellow\, Economics Program\, CSIS \nThis event is made possible thanks to the generous support of the Duff & Phelps Institute. \nFEATURING\n\n\n\nGeoffrey Okamoto\nFirst Deputy Managing Director\, International Monetary Fund\n\n\n\n\n\nSamar Maziad\nVice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\n\n\n\n\nKevin Gallagher\nProfessor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\n\n\n\n\n\nChristopher Campbell\nChief Strategist\, Duff & Phelps Institute
URL:https://globalbiodefense.com/event/the-effects-of-covid-19-on-latin-america-and-the-economic-outlook/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T090000
DTEND;TZID=America/New_York:20200924T124500
DTSTAMP:20200922T011659Z
CREATED:20200922T010030Z
LAST-MODIFIED:20200922T011659Z
UID:47128-1600938000-1600951500@globalbiodefense.com
SUMMARY:The Biological Event Horizon: No Return or Total Resilience
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on Sep. 24 entitled\, “The Biological Event Horizon: No Return or Total Resilience“. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for\, respond to\, and recover from biological threats. Decision makers must consider enhancements to policies and programs to better defend against the next biological threat as the Nation continues to respond to the crisis. COVID-19 will not be the last biological threat we face and it likely will not be the worst as the risk of natural and human-generated threats continues to increase with time. \nAt this meeting\, the Commission intends to address these emerging biological threats and innovative science and technology solutions to address them. \nSpeakers include: \n\nJaime Yassif\, PhD: Senior Fellow\, Global Biological Policy and Programs\, Nuclear Threat Initiative\nSohini Ramachandran\, PhD: Associate Professor of Biology\, Director of Graduate Studies for the Center for Computational Molecular Biology\, Associate Professor of Computer Science\, Brown University\nNita Madhav\, MSPH\, Chief Executive Officer\, President\, and Board Member\, Metabiota\nRepresentative Susan Brooks (R-IN):  Member\, Subcommittee on Health\, Committee on Energy and Commerce\, U.S. House of Representatives\nRepresentative Diana DeGette (D-CO): Chair\, Subcommittee on Oversight and Investigation\, Committee on Energy and Commerce\, U.S. House of Representatives\nKavita M. Berger\, PhD: Director\, Board on Life Sciences\, National Academies of Sciences\nLuciana Borio\, MD: Vice President\, Technical Staff\, In-Q-Tel; Former Director for Medical and Biodefense Preparedness\, National Security Council; Former Assistant Commissioner for Counterterrorism Policy and Director\, Office of Counterterrorism and Emerging Threats\, Office of the Chief Scientist\, FDA; and Former Senior Medical Advisor\, Office of the ASPR\, DHHS\n\nPlease visit the Bipartisan Commission on Biodefense website for more information. \nGlobal Biodefense is not affiliated with the Bipartisan Commission on Biodefense and is providing this listing as a courtesy to the community.
URL:https://globalbiodefense.com/event/the-biological-event-horizon-no-return-or-total-resilience/
CATEGORIES:Policy-Legislative,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T130000
DTEND;TZID=America/New_York:20200924T143000
DTSTAMP:20200922T011528Z
CREATED:20200919T010636Z
LAST-MODIFIED:20200922T011528Z
UID:47130-1600952400-1600957800@globalbiodefense.com
SUMMARY:Clearing the Path: Responding to Disasters During a Crisis
DESCRIPTION:The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is convening a diverse group of public-private partners to present\, Clearing the Path: Responding to Disasters During a Crisis\, a virtual discussion for National Preparedness Month\, on September 24\, 2020\, from 1:00 p.m. – 2:30 p.m. EST. \nWhen responding to natural disasters during a crisis\, such as the COVID-19 pandemic\, emergency responders\, hospitals\, and supply chains are working at capacity\, while the next hurricane\, wildfire\, or flood could be around the corner. For communities to adapt and respond to these compounding pressures\, they must understand how technologies can inform risk-based decision making in areas of neighborhood health monitoring\, supply chains\, evacuation planning\, crisis communications\, and information sharing among front-line responders. Innovation in predictive analytics\, modeling and simulation\, and mobility offer new solutions to tackle immediate challenges and prepare for emerging threats. \nTopics of this virtual discussion will include: \n\nUnderstanding how public-private partnerships are accelerating new solutions and business models to prepare for day-to-day emergencies and a national crisis.\nEducating community leaders on how new science and technology applications are enhancing resilience and protecting life-line systems and networks.\nWith increased frequency of new threats\, examining what new tools and policies are available to incentivize collaboration among government\, industry\, and foundations.\nWith communities investing in automated and digital technologies\, asking why this is important and how predictive data sets are changing the way we think about risk and preparedness.\n\nSpeakers include: \n\nDavid Maurstad\, Deputy Associate Administrator\, FEMA\n\n\nDuane Caneva\, Chief Medical Officer\, DHS Countering WMD Office\n\n\nTed Smith\, Ph.D.\, Wastewater Based Epidemiology\, Professor of Environmental Medicine\, University of Louisville and Advisor to Louisville Mayor\, Greg Fischer\n\n\nCatherine Cross\, Deputy Under Secretary\, DHS Science and Technology Directorate (S&T)\n\n\nDavid Corman\, Program Director\, Cyber-Physical Systems and Smart and Connected Communities\, National Science Foundation\n\n\nRichard Seline\, Executive Director\, Accelerate H2O\, Houston\, TX\n\n\nMichel Leonard\, Vice President and Senior Economist\, Insurance Information Institute\n\n\nModerator: David Alexander\, Director of Resilience Research and Partnerships\, DHS S&T\n\nTo register for the National Preparedness Month Virtual Discussion: Clearing the Path: Responding to Disasters During a Crisis\, please register here.
URL:https://globalbiodefense.com/event/clearing-the-path-responding-to-disasters-during-a-crisis/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/national-preparedness-clearing-path-disaster-crisis-response-dhs.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200925T130000
DTEND;TZID=America/New_York:20200925T150000
DTSTAMP:20200922T225747Z
CREATED:20200922T225650Z
LAST-MODIFIED:20200922T225747Z
UID:47168-1601038800-1601046000@globalbiodefense.com
SUMMARY:COVID-19: Current State of the Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘COVID-19: Current State of the Pandemic” on 25 September 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the current pandemic hotspots in the US and globally\, including the epidemiology of the current wave of infections; discuss country-wide testing needs to mitigate and suppress COVID-19 infections; and review the evidence regarding possible re-infections of COVID-19\, and interpret the data behind the newest therapeutic guidelines for COVID-19. \nRegister here to attend the virtual event.
URL:https://globalbiodefense.com/event/covid-19-current-state-of-the-pandemic/
CATEGORIES:Conference,Continuing Education
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T090000
DTEND;TZID=America/New_York:20200929T163000
DTSTAMP:20200922T180748Z
CREATED:20200922T180416Z
LAST-MODIFIED:20200922T180748Z
UID:47143-1601370000-1601397000@globalbiodefense.com
SUMMARY:Pediatric Countermeasures: Children's National - NIAID Partnership Virtual Symposium
DESCRIPTION:A virtual symposium highlighting pediatric COVID-19 and MIS-C pandemic efforts undertaken by the NIAID-Children’s Hospital partnership will take place virtually on 29 September\, 2020. \nThis one day symposium bringing together investigators\, researchers\, and clinicians from the National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions\, to discuss the creation\, progress\, and evolution of this first-of-its-kind collaboration between the NIAID at the National Institutes of Health and Children’s National\, a pediatric academic medical center. \nThis year\, the event will highlight the current COVID-19 and MIS-C pandemic\, with a specific focus on the pediatric population. \nHighlighted speakers and topics include: \n\nOverview of SARS-CoV-2: Anthony S. Fauci\, MD (NIAID)\nRole of NCATS in the the SARS-CoV-2 Response: Christopher P. Austin\, MD (NCATS)\nHumoral Immune Response: Jeffrey I. Cohen\, MD (NIAID)\nCellular Response (T and NK Cells): Michael Keller\, MD (Children’s National)\nImmunopathogenesis of MIS-C: Sarah E. Henrickson\, MD\, PhD (CHOP)\nGenomic Factors in SARS-CoV-2: Helen Su\, MD\, PhD (NIAID)\nHealth Disparities and SARS-CoV-2: Akilah Jefferson Shah\, MD\, MSc (UAMS)\nClinical Spectrum of SARS-CoV-2\, Implication for Schools Reopening: Dan M. Cooper\, M.D. (UC Irvine)\nMIS-C and Post SARS-CoV-2 Monitoring in Children: Roberta DeBiasi\, MD\, MS (Children’s National)\nPost SARS-CoV-2 Monitoring in Adults: Michael C. Sneller\, MD (NIAID)\nOverview of Vaccine Candidates: Peter Hotez\, MD\, PhD (Baylor)\nCurrent State of Vaccine Clinical Trials: Julie Ledgerwood\, DO (NIAID)\nOngoing Therapeutic Trials and Treatment Guidelines: Cliff Lane\, M.D. (NIAID)\nSARS-CoV-2 What Comes Next – Societal/Economic Impact: Ezekiel Emanuel\, MD\, PhD (UPenn)\n\nIn 2017\, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic\, immunologic\, auto-inflammatory\, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership\, co-led by H. Clifford Lane\, M.D.\, Deputy Director for Clinical Research and Special Projects at NIAID\, and Mark Batshaw\, M.D.\, Executive Vice President and Chief Academic Officer at Children’s National\, holds the mission to generate and apply knowledge to promote the prevention\, diagnosis\, treatment\, and cure of these childhood diseases through its work together. \nFor each area\, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies\, diagnoses\, treatments\, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda\, Maryland. Together\, the two institutions provide comprehensive\, state-of-the-art pediatric clinical support\, infrastructure\, and research capacity. These resources protect the safety of children\, ensure that they receive the highest quality of care\, and offer them the opportunity to participate in cutting-edge clinical research. In addition\, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology\, allergic\, and infectious diseases. \nThe collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children’s National\, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University. \nRegister here. \n 
URL:https://globalbiodefense.com/event/pediatric-countermeasures-childrens-national-niaid-partnership-virtual-symposium/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/niaid-childrens-national-covid-19-research-countermeasures.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T110000
DTEND;TZID=America/New_York:20200929T130000
DTSTAMP:20200922T003739Z
CREATED:20200922T002936Z
LAST-MODIFIED:20200922T003739Z
UID:47124-1601377200-1601384400@globalbiodefense.com
SUMMARY:Preventing Global Catastrophic Biological Risks: 2020 Munich Security Conference Tabletop Exercise Report
DESCRIPTION:NTI will host a report release event on 29 September to review lessons and recommendations from NTI’s 2020 Munich Security Conference Tabletop Exercise\, presenting key recommendations for actions that international stakeholders can take to meaningfully reduce catastrophic biological risks. \nThe virtual event is moderated by Andrew Hebbeler\, Senior Director and Lead Scientist\, NTI Global Biological Policy and Programs. \nSpeakers include: \n\nErnest J. Moniz\, Co-Chair and CEO\, NTI\nElhadj As Sy\, Co-Chair\, Global Preparedness Monitoring Board\nEmily Leproust\, CEO\, Twist Bioscience\nJaime Yassif\, Senior Fellow\, NTI Global Biological Policy and Programs\n\nThe presentations will be followed by Q&A with attendees. \nPlease visit the NTI website for additional information.
URL:https://globalbiodefense.com/event/preventing-global-catastrophic-biological-risks-launch-event-for-ntis-2020-munich-security-conference-tabletop-exercise-report/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://zoom.us/webinar/register/WN_UOTGXaUMTguXnxs7ileOTw
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T090000
DTEND;TZID=America/New_York:20200930T160000
DTSTAMP:20200922T212454Z
CREATED:20200922T212454Z
LAST-MODIFIED:20200922T212454Z
UID:47156-1601456400-1601481600@globalbiodefense.com
SUMMARY:Biomedical Informatics and Data Sciences in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Biomedical Informatics and Data Sciences in Africa‘ on 30 September 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will address emerging opportunities and challenges in the application of Data Science and Informatics technologies in various biomedical domains. It will also highlight some key challenges in the areas of data mining\, data quality\, standards for various types of data\, in addition to addressing how cutting-edge data analytics\, predictive modeling and Machine Learning\, and methods for simulations can advance human health in Africa. \nModerator: \nDarrell Hurt\, National Institute of Allergy and Infectious Diseases\, National Institutes of Health (NIH) \nGeetha Senthil\, National Institute of Mental Health\, NIH\nPanelists:\nAgnes Abdoulaye Banire Diallo\, University of Quebec-Montreal (UQAM) \nElaine Nsoesie\, Boston University \nGeoffrey Siwo\, University of Notre Dame \nDina Machuve\, Nelson Mandela African Institution of Science and Technology \nMoustapha Cisse\, Google AI \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/biomedical-informatics-and-data-sciences-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T130000
DTEND;TZID=America/New_York:20200930T143000
DTSTAMP:20200927T191940Z
CREATED:20200827T174326Z
LAST-MODIFIED:20200927T191940Z
UID:47213-1601470800-1601476200@globalbiodefense.com
SUMMARY:DTRA Chemical and Biological Technologies Department: Student Workforce Opportunities
DESCRIPTION:The Defense Threat Reduction Agency’s Chemical and Biological Technologies Department (DTRA-CB) will host a University Engagement Webinar: Student Workforce Opportunities on Wednesday\, Sept. 30\, 2020. \nDuring this webinar\, participants will learn about internships\, scholarships\, fellowships\, postdoctoral and employment opportunities available through the DoD and federal government. \nTopics that will be discussed include: \n\nMore on DTRA-CB’s role as the DoD’s Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)\nNational Research Council (NRC) Research Associateship (Postdoctoral) Program\nPathways Programs: Pathways Internship Programs\, Recent Graduates Program and the Presidential Management Fellows Program (PMF)\nNavigating USAJOBS for employment opportunities\nScience\, Mathematics\, and Research for Transformation (SMART) Scholarship-for-Service Program benefits\, application deadlines and success stories\n\nLearn more: http://bit.ly/dtracbd-student-workforce
URL:https://globalbiodefense.com/event/dtra-chemical-and-biological-technologies-department-student-workforce-opportunities/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/08/defense-threat-reduction-chemical-biological-defense-dtra-cbd-jsto-university-engagement-global-biodefense.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20200927T192759Z
CREATED:20200927T192759Z
LAST-MODIFIED:20200927T192759Z
UID:47216-1601546400-1601550000@globalbiodefense.com
SUMMARY:Accelerating Detection of Disease: UKRI Industry Briefing for Life Sciences Sector
DESCRIPTION:The UK Research and Innovation (UKRI)-funded Accelerating Detection of Disease (ADD) program will host a webinar on 1 October 2020 for life science companies to learn more about partnering and investment opportunities. \nOver the next four years the ADD program will recruit five million volunteers to support research intended to improve early detection\, risk stratification\, and early intervention for chronic diseases. \nADD volunteers will provide biological samples and health related data. With their consent\, volunteers’ data will be linked to NHS records\, and ADD will also offer volunteers feedback about their health\, if they choose. Some will be invited to provide repeat samples and join follow-on studies designed to test the potential of new diagnostic tests or treatments\, particularly if they’re at higher risk for certain diseases. \nThe unrivalled depth and detail of the ADD initiative will make it a unique resource for health research. Researchers from across academia and industry will have the chance to work with ADD to conduct studies that could improve the way we detect\, diagnose and treat diseases. \nSpeakers at the seminar include: \n\nAlison Cave\, Accelerating Detection of Disease challenge director at UK Research and Innovation\nAndrew Roddam\, CEO\, Early Disease Detection Research Project UK Ltd\, the charity that runs the ADD programme\nFiona Reddington\, Exec Director of Partnerships\, Early Disease Detection Research Project UK Ltd.\n\nADD is funded by £79 million from UKRI’s Industrial Strategy Challenge Fund which is expected to be matched by funding of up to £160 million from industry.
URL:https://globalbiodefense.com/event/accelerating-detection-of-disease-ukri-industry-briefing-for-life-sciences-sector/
CATEGORIES:Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T120000
DTEND;TZID=America/New_York:20201001T130000
DTSTAMP:20200923T194149Z
CREATED:20200923T194110Z
LAST-MODIFIED:20200923T194149Z
UID:47182-1601553600-1601557200@globalbiodefense.com
SUMMARY:HDIAC Webinar: Agnostic Compact Demilitarization of Chemical Agents
DESCRIPTION:Join HDIAC Thursday\, October 1\, from 1200 to 1300 EDT for our next webinar presentation titled “Agnostic Compact Demilitarization of Chemical Agents (ACDC).” \nPlease register in advance for the webinar at: https://www.anymeeting.com/PIID=EF54DD81854C3B \nThe safe destruction of chemical warfare agents (CWAs) and organic precursors is a timely\, costly\, and significant challenge for the international community. Today\, for example\, there are no approaches that exploit chemistries that are truly agnostic in terms of the agents that can be processed. Additionally\, current approaches require transport of agents from the storage site to a neutralization site\, which can add significant cost and time to the destruction process. \nDARPA’s ACDC program explored new technologies for neutralization of bulk stores of CWAs and organic precursors at or near the site of storage. ACDC developed and demonstrated the technologies needed to construct a transportable\, prototype system that converts organic compounds into constitutive carbon/nitrogen/phosphorous/sulfur oxides and stable alkali or alkaline earth metal salts. The ACDC system featured chemistries for agent destruction and sequestration of halogens and other components using locally available or easily transportable resources. This webinar describes the DARPA ACDC program and its exploration of neutralization of bulk stores of CWAs and organic precursors at or near the site of storage. \nABOUT THE SPEAKER \nMr. Darrel Johnston manages the Pharmaceutical Program and Pilot Plant Operations section of the Southwest Research Institute which works with government and commercial clients in the areas of drug modeling\, synthesis\, scale-up\, and production.    With reactors up to 200 liters\, he oversees the operation of a pilot plant facility compliant with current Good Manufacturing Practices\, Good Laboratory Practice\, and Drug Enforcement Agency controlled substances as needed.  Projects have included treatment or preventative drugs for cancer\, heart attack\, COVID-19\, EBOV\, SUDV\, MARV\, and poisoning from opioids\, organophosphates\, and cyanide. Mr. Johnston’s chemical demilitarization experience includes construction\, systemization\, start-up\, operations\, and closure phases of chemical warfare agent demilitarization at the Johnston Atoll Chemical Agent Destruction System (JACADS)\, Umatilla Chemical Agent Disposal Facility (UMCDF)\, Pine Bluff Chemical Agent Disposal Facility\, and Newport Chemical Agent Disposal Facility (NECDF).  He facilitated air sampling and analysis for chemical agent BZ\, for the demolition of the BZ Disposal Facility (BZDF) in Pine Bluff\, AR.  Mr. Johnston served as the on-site Laboratory Manager for the JACADS\, UMCDF\, and NECDF facilities and was responsible for leadership and day-to-day operation of the agent and non-agent monitoring systems including the analytical laboratories.  His direct support of demilitarization laboratory operations spanned 17 years from 1990-2008. Mr. Johnston was also the Southwest Research Institute project manager for the Defense Advanced Research Projects Agency (DARPA) Agnostic Compact Demilitarization of Chemicals (ACDC) project.  While serving in this role\, he investigated the use of a diesel engine for the destruction of chemical warfare agents and making use of media such as soil for acid gas scrubbing.
URL:https://globalbiodefense.com/event/hdiac-webinar-agnostic-compact-demilitarization-of-chemical-agents/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/hdiac-webinar-agnostic-compact-demilitarization-chemical-agents.jpg
LOCATION:https://www.anymeeting.com/AccountManager/RegEv.aspx?PIID=EF54DD81854C3B
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201002T130000
DTEND;TZID=America/New_York:20201002T150000
DTSTAMP:20200923T002332Z
CREATED:20200923T002332Z
LAST-MODIFIED:20200923T002332Z
UID:47176-1601643600-1601650800@globalbiodefense.com
SUMMARY:Got Masks? PPE Compliance and Fatigue in First Responder Realms
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Got Masks? PPE Compliance and Fatigue in First Responder Realms‘ on 2 October 2020 as part of its virtual webinar series. \nAre personnel becoming less diligent with PPE? Is there a significant element of PPE fatigue? Do you know what the PPE requirements are when not actively providing patient care? What about PPE requirements in the office\, ambulance\, and firehouse? Join NETEC for a Town Hall meeting and discuss the importance of PPE in the First Responder Environment and learn techniques to deal with PPE fatigue and improve compliance? Submit your questions for the panel during registration and they will be answered during the Town Hall session. \nPlease register here: http://bit.ly/netec-ppe-compliance
URL:https://globalbiodefense.com/event/got-masks-ppe-compliance-and-fatigue-in-first-responder-realms/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T090000
DTEND;TZID=America/New_York:20201007T160000
DTSTAMP:20200922T214447Z
CREATED:20200922T214447Z
LAST-MODIFIED:20200922T214447Z
UID:47158-1602061200-1602086400@globalbiodefense.com
SUMMARY:Innovative Approaches to Improve Maternal and Child Health
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovative Approaches to Improve Maternal and Child Health‘ on 7 October 2020 as part of the DS-I Africa Virtual Forum series. \nMaternal and child health outcomes in Africa still lag behind the rest of the world despite prioritization as a topic of focus within the United Nations Sustainable Development Goals (SDGs). Partners from  country-level governments\, research institutions\, private sector program funding agencies and non-governmental organizations are involved in various capacities and across disciplines\, implementing activities to reduce the enormous burden of high mortality and morbidity of women and children on the African continent.  Nonetheless\, millions of women and children experience death and severe morbidity each year despite these efforts. In this session we will 1) address the gap in availability of existing databases and collective data focused on pregnancy and the peripartum period; 2) explore emerging use of linked data such as electronic medical records as a tool for conducting research\, analyzing data and creating tools for interventions; and 3) develop concrete recommendations for a strategy to utilize data science to improve maternal and child health outcomes from pre-pregnancy to pregnancy and delivery and throughout the mother and child’s life course. \nIntroductions:\nVesna Kutlesic\, US Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\, National Institutes of Health (NIH) \nDiana Bianchi\, Director of NICHD\, NIH \nNaveen Rao\, MD\, Senior Vice President & Senior Advisor to the President\, Health Initiative\, The Rockefeller Foundation \nModerator:\nDenise Russo\, NICHD\, NIH \nPanelists:\nAndre van der Kouwe\, Ph.D.\, Associate Professor in Radiology\, Harvard Medical School\, Assistant in Physics\, Massachusetts General Hospital \nLilla Zöllei\, Ph.D.\, Assistant Professor of Radiology\, Harvard Medical School \nMoses Alobo\, M.D.\, Program Manager\, Grand Challenges Africa Programme at African Academy of Sciences \nAlash’le Abimiku\, Ph.D.\, Professor in Epidemiology & Public Health\, University of Maryland School of Medicine; Executive Director\, International Research Center of Excellence at the Institute of Human Virology-Nigeria \nAmel Ghouila\, Ph.D.\, Bioinformatician\, Capacity Builder\, Pan African Bioinformatics \nTo participate in the discussion and session\, you must register for this DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovative-approaches-to-improve-maternal-and-child-health/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T090000
DTEND;TZID=America/New_York:20201014T160000
DTSTAMP:20200922T214817Z
CREATED:20200922T214735Z
LAST-MODIFIED:20200922T214817Z
UID:47160-1602666000-1602691200@globalbiodefense.com
SUMMARY:Using Data Science to Fight COVID-19
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Using Data Science to Fight COVID-19‘ on 14 October 2020 as part of the DS-I Africa Virtual Forum series. \nModerator:\nStefan Jaeger\, National Library of Medicine\, National Institutes of Health \nPanelists:\nAgnes Kiragga\, Ph.D.\, Head of Statistics and Data Management Unit and Senior Research Scientist\, Infectious Diseases Institute (IDI)\, Makerere University College of Health Sciences \nNirmal Ravi\, MD\, Ph.D. \nAli H. Mokdad\, Ph.D.\, Professor of Health Metrics Sciences\, the Institute for Health Metrics and Evaluation; Chief Strategy Officer\, Population Health at the University of Washington \nElaine Nsoesie\, Ph.D.\, Assistant Professor of Global Health\, Boston University School of Public Health \nFrank Kagoro\, Ph.D.\, Research Physician\, MORU Tropical Health Network and WorldWide Antimalarial Resistance Network \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/using-data-science-to-fight-covid-19/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201016T130000
DTEND;TZID=America/New_York:20201016T150000
DTSTAMP:20200923T001907Z
CREATED:20200923T001702Z
LAST-MODIFIED:20200923T001907Z
UID:47174-1602853200-1602860400@globalbiodefense.com
SUMMARY:Pediatric Perspectives During a Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Pediatric Perspectives During a Pandemic” on 16 October 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the epidemiology of acute COVID-19\, including post-infectious manifestations and the unique aspects of caring for children during a pandemic. NETEC will also discuss the features of MIS-C and how to devise a diagnostic and acute management plan and integrate potential post-recovery complications into the development of follow-up plans for a child with MIS-C. \nRegister for the event here: http://bit.ly/netec-pediatric-pandemic
URL:https://globalbiodefense.com/event/pediatric-perspectives-during-a-pandemic/
CATEGORIES:Continuing Education,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201016T140000
DTEND;TZID=America/Los_Angeles:20201016T163000
DTSTAMP:20201006T183317Z
CREATED:20201006T183317Z
LAST-MODIFIED:20201006T183317Z
UID:47329-1602856800-1602865800@globalbiodefense.com
SUMMARY:Effects of the COVID-19 Pandemic on the Life Science Enterprise
DESCRIPTION:The National Academies’ Board on Life Sciences will host two panel sessions on October 16 on Effects of the COVID-19 Pandemic on the Life Science Enterprise and Inequities in the Life Sciences: Understanding the Issues. \nHow has the COVID-19 pandemic affected research\, education\, and workforce in the life sciences? This session will explore short and long-term consequences of the pandemic on life science research\, education and training\, career progression as a first step to examining resiliency within the life science research enterprise. \nInequities in the Life Sciences: Understanding the Issues \n2:00-3:00 PM \nHow do such factors as gender\, race\, and socioeconomic level affect educational\, research\, and career opportunities in the life sciences? This session will explore consequences associated with inequities in the life sciences\, needs for preventing societal injustices\, and opportunities for addressing those needs. \nSession moderator: Keegan Sawyer\, National Academies’ Board on Life Sciences \nPanelists: \n\nScott V. Edwards\, Harvard University\nPaul Barber\, University of California Los Angeles\nEdie M. Stringfellow\, MassBio\nPaul Turner\, Yale University\nShirley Malcom\, SEA Change\, American Association for the Advancement of Science\n\nEffects of the COVID-19 Pandemic on the Life Science Enterprise \n3:10-4:40 PM \nSession moderator: Nancy Connell\, Johns Hopkins Center for Health Security \nPanelists: \n\nSusan Singer\, Rollins College\nArielle Baker\, National Academies of Sciences\, Engineering\, and Medicine\nJan O. Korbel\, European Molecular Biology Laboratory\nErik Prentice\, 6F\nHolden Thorp\, AAAS/Science\nMarc Malandro\, Chan Zuckerberg Initiative\nMark Alexander\, 100 Black Men of America\, Inc\n\nThese sessions will be live streamed on the Board on Life Science website \nLearn more: http://bit.ly/nasemlifesciences \n 
URL:https://globalbiodefense.com/event/effects-of-the-covid-19-pandemic-on-the-life-science-enterprise/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20201021T090000
DTEND;TZID=America/Los_Angeles:20201021T160000
DTSTAMP:20200922T215239Z
CREATED:20200922T215225Z
LAST-MODIFIED:20200922T215239Z
UID:47162-1603270800-1603296000@globalbiodefense.com
SUMMARY:Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovations in Health Metrics Sciences: Measuring\, Mapping\, and Monitoring Morbidity and Mortality at the Regional\, National\, and Local Levels in Africa‘ on 21 October 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will highlight the emerging field of health metrics sciences and its role in measuring and monitoring summary measures of health in Africa to better develop and implement measures to reduce the burden of disease. Identify challenges and opportunities relevant to the DS-I Africa initiatives. Address the increasing role that health metrics is playing in informing and prioritizing systems-level health interventions and broad public health-related decision making. Discuss how health metrics and data science can inform and evaluate more effective integrated care efforts at the intersection of infectious diseases and the rapidly growing burden of chronic\, non-communicable diseases \nModerator:\nKaren Sliwa\, University of Cape Town \nPanelists:\nMayowa Ojo Owolabi\, University of Ibadan \nDebbie Bradshaw\, South African Medical Research Council \nAna Olga H Mocumbi\, Mondlane University \nAli H. Mokdad\, Institute for Health Metrics and Evaluation \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovations-in-health-metrics-sciences-measuring-mapping-and-monitoring-morbidity-and-mortality-at-the-regional-national-and-local-levels-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T120000
DTEND;TZID=America/New_York:20201021T133000
DTSTAMP:20201006T184848Z
CREATED:20201006T184848Z
LAST-MODIFIED:20201006T184848Z
UID:47335-1603281600-1603287000@globalbiodefense.com
SUMMARY:Digital Genetic Sequences and International Data Sharing Policies
DESCRIPTION:The National Academies’ Board on Life Sciences will host a virtual panel discussion on October 21\, 2020 on Digital Genetic Sequences and International Data Sharing Policies. \n\nHow does the complex policy environment affect sharing of genetic sequence data internationally to address critical and pressing societal needs? This session will explore the implications of ongoing international discussions associated with sharing genetic sequence data. What policy frameworks govern the collection and sharing of digital sequence information around the world? What considerations are important for balancing open access and protection of genetic sequence data? \nSession moderator: Todd Kiuken\, North Carolina State University. \nPanelists: \n\nPatrick Reilly\, Department of State\nIan Watson\, Department of Health and Human Services\nDiane DiEuliis\, National Defense University\nHarris Lewin\, Earth BioGenome Project\n\nLearn more: http://bit.ly/nasem-lifesci-oct2020
URL:https://globalbiodefense.com/event/digital-genetic-sequences-and-international-data-sharing-policies/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T134500
DTEND;TZID=America/New_York:20201021T150000
DTSTAMP:20201006T184647Z
CREATED:20201006T184252Z
LAST-MODIFIED:20201006T184647Z
UID:47333-1603287900-1603292400@globalbiodefense.com
SUMMARY:Biotechnology Innovations in the 21st Century
DESCRIPTION:The National Academies’ Board on Life Sciences will host a virtual panel discussion on October 21\, 2020 on Biotechnology Innovations in the 21st Century. \n\nHow is the convergence of the life sciences with other scientific disciplines and fields enabling new capabilities beyond medicine and agriculture? This session will explore innovations in biotechnology that leverage advances in several scientific disciplines\, enabling new applications and enhancing the bioeconomy. \nSession moderator: Clem Fortman\, Engineering Biology Research Consortium \nPanelists: \n\nKerri Dugan\, Defense Advanced Research Projects Agency\nMichelle Rozo\, Department of Defense\nTodd Anderson\, Department of Energy\nJohn Beieler\, Office of the Director of National Intelligence\nTheresa Good\, National Science Foundation\nElizabeth Strychalski\, National Institute of Standards and Technology\n\n\n\nLearn more: http://bit.ly/nasem-lifesci-oct2020
URL:https://globalbiodefense.com/event/biotechnology-innovations-in-the-21st-century/
CATEGORIES:Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/nasem-board-life-sciences-covid-19-pandemic-effects.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201022T100000
DTEND;TZID=America/New_York:20201022T170000
DTSTAMP:20200927T172033Z
CREATED:20200927T172033Z
LAST-MODIFIED:20200927T172033Z
UID:47197-1603360800-1603386000@globalbiodefense.com
SUMMARY:FDA Vaccines and Related Biological Products Advisory Committee Meeting
DESCRIPTION:On October 22\, 2020\, the Center for Biologics Evaluation and Research’s (CBER)\, Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session\, to discuss\, in general\, the development\, authorization and/or licensure of vaccines to prevent COVID-19. No specific application will be discussed at this meeting. \nFDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting\, any background material will be made publicly available at the time of the advisory committee meeting\, and additional materials will be posted on FDA’s website after the meeting. \nMaterials for this meeting will be available at the Vaccines and Related Biological Products Advisory Committee meetings main page. \nThe meeting will include slide presentations with audio components to allow the presentation of materials in a manner that most closely resembles an in-person advisory committee meeting. \nPublic Participation Information\nInterested persons may present data\, information\, or views\, orally or in writing\, on issues pending before the committee. \n\nWritten submissions may be made to the contact person on or before October 15\, 2020.\nOn October 22\, 2020\, oral presentations from the public will be scheduled between approximately 2:30 p.m. and 3:30 p.m. EST.\n\nThose individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present\, the names and addresses of proposed participants\, and an indication of the approximate time requested to make their presentation on or before October 7\, 2020. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session\, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by October 8\, 2020. \nWebcast Information\nCBER plans to provide a free of charge\, live webcast of the Vaccines and Related Biological Products Advisory Committee meeting. If there are instances where the webcast transmission is not successful; staff will work to re-establish the transmission as soon as possible. \nThe online web conference meeting will be available at:\nhttp://fda.yorkcast.com/webcast/Play/c26e83a0f77a412296949f4f43af4c981d
URL:https://globalbiodefense.com/event/fda-vaccines-and-related-biological-products-advisory-committee-meeting/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201028
DTSTAMP:20200927T165438Z
CREATED:20200802T163328Z
LAST-MODIFIED:20200927T165438Z
UID:47192-1603756800-1603843199@globalbiodefense.com
SUMMARY:BARDA Industry Day 2020
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA) will host a virtual Industry Day on October 27\, 2020 to learn about U.S. Government medical countermeasure priorities\, interact with the BARDA and HHS ASPR teams\, and network with public and private sector colleagues. \nFeatured speakers and breakout presenters will address the many ways BARDA is actively addressing the current COVID-19 pandemic crisis and forging new partnerships while remaining vigilant and prepared for any new threats that may arise. \nBARDA Industry Day 2020 will include breakout sessions\, virtual networking opportunities\, and an address by Acting BARDA Director\, Dr. Gary Disbrow. Lightning Talk sessions will be available to selected applicants\, which provide an opportunity to present their technologies to an audience of BARDA specialists\, industry partners\, and potential collaborators. \nThe conference is open to anyone in the public who wishes to attend. The content is mainly geared towards healthcare research professionals and medical countermeasure developers\, government agency staff\, pharmaceutical professionals\, and scientific researchers and academics. \nThe breakout sessions and plenary discussions will be available for viewing on the conference website after the event \nLearn more: http://bit.ly/bardaindustryday2020 \nEditor’s Update 31 Aug: The Lightning Talks application submission period is now closed. Event registration is still open.
URL:https://globalbiodefense.com/event/barda-industry-day-2020/
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/barda-industry-day-2020.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201027
DTEND;VALUE=DATE:20201031
DTSTAMP:20200922T181413Z
CREATED:20200922T181413Z
LAST-MODIFIED:20200922T181413Z
UID:47146-1603756800-1604102399@globalbiodefense.com
SUMMARY:NIH Program Funding and Grants Administration Virtual Seminar
DESCRIPTION:The National Institutes of Health invites you to take part in a unique opportunity to learn more about\nworking with the NIH grants process\, programs\, policies\, and staff at the 2020 NIH Virtual Seminar on Grants Administration and Program Funding 27-30 October 2020. \nThis seminar is designed for those who are new to working with the NIH grants process – administrators\, early stage investigators\, researchers\, graduate students\, etc. For those with more experience\, NIH experts provide a few sessions that are designed for participants that are more advanced and are focused on more in-depth polices and processes. \nWhat to expect?\nYou may be familiar with the NIH Regional Seminar and wondering if this is the same event moved to a virtual environment. There are some similarities\, but also some modifications to accommodate the new format. \n\nThis event is scheduled over four days in the afternoons only (U.S. New York time zone – EDT). Sessions 1:00 PM – 5:45 PM\nThere are three tracks of sessions which are open to any participants on any given day without any further registration.\nAll sessions are 45-minute sessions with a 15 minute break before the next session begins. Some are live\, while others are simulive (a combination of a pre-recorded video and live Q&A).\nRepresentatives from NIH programs\, offices\, and Institutes and Centers will be presenting and attending booths in the Meet the Experts Exhibit Hall.\nThe seminar is free!\n\nTuesday\, October 27 – Thursday\, October 29 \n\n\nTrack 1\nNIH Grant Process \n\n\nLooking for an overview of the NIH Grant Process from application preparation to post-award management? This is the track for you! \n\n\n\n\nTrack 2\nNIH Grant Policies & Programs \n\n\nWanting to learn about specific programs offered by NIH or receive updates on the latest NIH & HHS policies? Check out this track. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nSessions in this track are designed to be more interactive with Question & Answer sessions and case studies. \n\n\nFriday\, October 30 \nTracks are slightly different with sessions that are primarily focused on a general topic or program: \n\n\nSpecial Focus 1:\nHuman Subjects in Research \n\n\nIf your research meets the definition of involving human subjects\, then you’ll want to participate in these sessions provided by OHRP and NIH. \n\n\n\n\nSpecial Focus 2:\nSEEDing the Marketplace \n\n\nThe NIH SEED (Small business Entrepreneurial Education) team is providing a track focused on developing relationships and building relationshops for innovators to move towards production. \n\n\n\n\nTrack 3\nLet’s Talk About It \n\n\nVisit this track for sessions focused on business\, inventions\, and data. Visit for more interactive with Q&A and/or case studies. \n\n\nWho are the Presenters?\nThis seminar involves over 50 NIH and HHS presenters and over 100 additional experts at the NIH booths who are eager to educate\, share\, and hear your questions during this event. It’s your opportunity to interact with NIH policy officials\, grants management\, program and review staff\, and representatives from the HHS Office for Human Research Protections (OHRP) and HHS Office of Research Integrity. Select the “Presenters” tab to see a selection of NIH & HHS experts who will be providing presentations. \nView the full AGENDA \nRegister HERE.
URL:https://globalbiodefense.com/event/nih-program-funding-and-grants-administration-virtual-seminar/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T133000
DTEND;TZID=America/New_York:20201027T163000
DTSTAMP:20201023T154239Z
CREATED:20201012T153755Z
LAST-MODIFIED:20201023T154239Z
UID:47618-1603805400-1603816200@globalbiodefense.com
SUMMARY:COVID-19 and the Geography of Vulnerability
DESCRIPTION:The National Academies Geographical Sciences Committee will host a virtual keynote talk on Oct. 27 on “COVID-19 and the Geography of Vulnerability“. \nOur understanding of the geographic spread of COVID-19 has largely been based on national-scale epidemiological models\, while the place-based responses to community-level impacts of the disease have mainly been informed by local-scale surveys and reports of the lived experiences of individuals within those communities. Geographers have the capacity to integrate local and population-scale research\, yet examples of this type of integration are rare among studies of vulnerability. \nDuring this meeting\, the National Academies’ Geographical Sciences Committee will examine the geography of vulnerability in the context of the COVID-19 pandemic. This meeting will be held to discuss the following questions and consider potential next steps that could be taken to advance the capacity to characterize\, predict\, and alleviate vulnerability. \nFeaturing Keynote Talk by Dr. Eric Tate\, Associate Professor\, University of Iowa\nSocial Vulnerability and Place-based Risk \nPanelists \nDr. Elisabeth Root\, Professor\, Ohio State University: Identifying Vulnerability from the COVID-19 Data: What is Possible and What is Missing? \nDr. Peter Smittenaar\, Director of Data Science and AI\, Surgo Foundation: COVID-19 Community Vulnerability Index: Capturing the Geographical Dimensions of Vulnerability \nDr. LaToya Eaves\, Assistant Professor\, University of Tennessee: Intersectional Geographies and COVID-19 \nDr. Karen Falconer Al-Hindi\, Professor\, University of Nebraska\, Omaha \nDr. Aaron Strong\, Economist\, RAND Corporation \nPlease visit NASEM’s COVID-19 and the Geography of Vulnerability event website for more information.
URL:https://globalbiodefense.com/event/covid-19-and-the-geography-of-vulnerability/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/10/covid-19-georgraphy-vulnerability-nasem.jpg
LOCATION:
END:VEVENT
END:VCALENDAR